Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iveric Bio Inc (NQ: ISEE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iveric Bio Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 02, 2022 From IVERIC bio, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session December 01, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock November 30, 2022 From IVERIC bio, Inc. Via Business Wire Analyst Ratings for IVERIC bio November 10, 2022 IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: Via Benzinga Where IVERIC bio Stands With Analysts November 10, 2022 IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: Via Benzinga IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript November 03, 2022 ISEE earnings call for the period ending September 30, 2022. Via The Motley Fool Iveric Bio Announces Proposed Offering of Common Stock November 30, 2022 From IVERIC bio, Inc. Via Business Wire How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market November 23, 2022 Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. Via Benzinga Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday November 21, 2022 U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga IVERIC bio: Q3 Earnings Insights November 03, 2022 IVERIC bio (NASDAQ:ISEE) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday November 21, 2022 Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. Via Benzinga Nasdaq Down 0.5%; Clearfield Shares Spike Higher November 18, 2022 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday. Via Benzinga Why Is Iveric Bio (ISEE) Stock Up 25% Today? November 18, 2022 Biotechnology firm Iveric Bio shot up on a regulatory green light for its key therapeutic, sparking interest in high-risker play ISEE stock. Via InvestorPlace Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session November 18, 2022 Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 18, 2022 Via Benzinga Stocks Brushing Off Latest Fed Fears November 18, 2022 The Dow Jones Industrial Average is up triple digits midday, while the S&P 500 Index and Nasdaq Composite sit hesitantly higher. Via Talk Markets Nasdaq Turns Lower; Crude Oil Down Over 3% November 18, 2022 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday. Via Benzinga Dow Surges Over 100 Points; Foot Locker Earnings Top Views November 18, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. Via Benzinga Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment November 18, 2022 The delay is at Apellis' behest. The company wanted to include updated data in its request. Via Investor's Business Daily 12 Health Care Stocks Moving In Friday's Pre-Market Session November 18, 2022 Via Benzinga Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket November 18, 2022 Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday November 18, 2022 It's time to start closing out the trading week with a dive into the biggest pre-market stock movers for Friday morning! Via InvestorPlace IVERIC bio Secures Breakthrough Therapy Tag For Its Flagship Geographic Atrophy Candidate November 18, 2022 Via Benzinga Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session November 18, 2022 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session November 17, 2022 Via Benzinga Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy November 17, 2022 From IVERIC bio, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 November 10, 2022 Upgrades Via Benzinga Iveric Bio to Present at Upcoming Investor Conferences November 04, 2022 From Iveric Bio Via Business Wire Apellis Pharma Crashes On Unexpected Delay For Eye Drug — A Boon For Iveric Bio November 04, 2022 Apellis long said it wouldn't wait for 24-month data for its eye drug. Apellis was wrong. Via Investor's Business Daily Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol for the Treatment of Geographic Atrophy November 03, 2022 From IVERIC bio, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.